Silence Therapeutics plc (SLN) Stock Profile — Insider Trades & Financials

Revenue$34.0K

Net Income-$11.8M

EPS$-0.63

Gross Margin64.7%

Market Cap$789.3M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

Iain Ross

CEO & Executive Director

Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.

Founded: 1994
Employees: 120
Headquarters: LONDON, W6 7AP, United Kingdom
Website: www.silence-therapeutics.com

⚡

Core Efficiency

ROE?

-18.89%

ROA?

-8.95%

D/E Ratio?

1.11

Op. Margin?

-36650.00%

📊

Profitability Ratios

Net Margin?

-34617.65%

Loading company sections...

Silence Therapeutics plc

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness